Antiretroviral Therapy Journal Articles

• Comorbidities and Co-Medications Among People With HIV How prevalent are comorbidities and the use of non-ART co-medications among people living with HIV?
  HIV Medicine, May 19, 2022
• Immune Response After BNT162b2 Vaccination in HIV on ART How effective is the BNT162b2 COVID-19 vaccine among people living with HIV?
  HIV Medicine, May 12, 2022
• Reflections on a Specialist HIV Menopause Service Find out how a specialist HIV menopause service can help address the unmet health needs of women living with HIV.
  HIV Medicine, May 05, 2022
• Associations Between HIV, ART and Preterm Birth In what ways might HIV and antiretroviral exposure impact the risk for preterm birth?
  HIV Medicine, April 28, 2022
• Safety and Tolerability of Once Daily BIC/FTC/TAF for PEP Is this PEP regimen a safe and effective means of preventing HIV infection after high-risk sexual exposure?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, April 27, 2022
• HCV Cascade of Care Among People Living With HIV This study characterized the HCV care cascade among people living with HIV in New South Wales, comparing HCV testing and treatment uptake between pre- and post-introduction of DAAs in Australia.
  Journal of Viral Hepatitis, April 25, 2022
• Comorbidities in Women Living With HIV Gain a better understanding of the prevalence and impact of coexisting conditions among women living with HIV.
  HIV Medicine, April 21, 2022
• Safety and Immunogenicity of SARS-CoV-2 Vaccines in HIV Two doses of the SARS-CoV-2 mRNA vaccines are effective and well tolerated with no reported adverse events among people with HIV receiving ART.
  AIDS, April 18, 2022
• Integrating Services to Improve Care for Women With HIV Learn how integrating services could positively impact the quality of care for women living with HIV.
  HIV Medicine, April 14, 2022
• Impact on Weight Gain With INSTI-Containing ART Regimens A new analysis finds that INSTI-based ART regimens may not be associated with accelerated rates of weight gain among treatment naive adults with HIV.
  HIV Medicine, April 07, 2022
• Viral Suppression After Transition to DTG-Based ART What have we learned about the virological effectiveness of transitioning from NNRTI-based regimens to DTG-containing ART?
  HIV Medicine, March 31, 2022
• Lower Incidence of HIV-1 Blips During INSTI-Based ART A new study observes a lower number of viral blips during INSTI-based treatment compared with other ART regimens.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, March 30, 2022
• Problems Associated With Ageing Among Older People With HIV A better understanding of the issues linked to ageing seen in older people with HIV could lead to improvements in HIV services among this group.
  HIV Medicine, March 24, 2022
• Alcohol, Smoking, Drug Use and HIV Virological Outcomes Might alcohol, cigarette and drug use impact ART adherence and virological outcomes among people living with HIV?
  HIV Medicine, March 17, 2022
• Impaired Response to COVID-19 Vaccination in Advanced HIV These results bring into question the efficacy of two doses of COVID-19 vaccines among people with advanced HIV infection.
  AIDS, March 17, 2022
• Outcomes of Inpatients With and Without HIV With COVID-19 Are there differences in COVID-19 outcomes between people with and without HIV?
  HIV Medicine, March 10, 2022
• B/F/TAF Efficacy in Those With Preexisting INSTI Resistance Is this HIV treatment option an effective means of achieving virologic suppression among those who are resistant to INSTI-based regimens?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, March 10, 2022
• SARS-CoV-2 Vaccine Immunogenicity in Older People With HIV A new study provides insight into SARS-CoV-2 immunogenicity after COVID-19 vaccination in people living with HIV.
  HIV Medicine, March 03, 2022
• Atazanavir With Cobicistat in Pregnant Women With HIV Is this ART regimen a safe HIV treatment during pregnancy?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, March 03, 2022
• Impact of COVID-19 on HIV Testing and Care Provision The significant impacts of the COVID-19 pandemic on access to HIV testing and treatment could have long-term consequences.
  HIV Medicine, February 24, 2022